0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
ARTICLE |

Arginine-Induced Hyperkalemia in Renal Failure Patients

Philip Hertz, MD; James A. Richardson, MD
Arch Intern Med. 1972;130(5):778-780. doi:10.1001/archinte.1972.03650050096020.
Text Size: A A A
Published online

The intravenous infusion of arginine hydrochloride stimulates growth hormone (GH) secretion and is considered a nonhazardous test of pituitary function.1 This report describes potentially dangerous increases in the concentration of plasma potassium (plasma K+) in uremic patients receiving arginine infusions.

Patient Summary  A 23-year-old anephric housewife received two separate infusions of 30 gm of arginine hydrochloride in 600 ml of water over 30 minutes as part of an investigation of GH metabolism in chronic renal failure. The infusions were given on the day before and the day after a two-week period of intensive hemodialysis. One hour after the end of the second infusion, the patient developed numbness of the lips and tongue and diffuse warmth. These symptoms were followed by abdominal pain, vomiting, lower extremity paresthesias, and generalized muscle weakness. Her plasma K+ at this time was 8.4 mEq/liter and the pH of her arterial blood, 7.40. An infusion

Topics

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

Correspondence

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Submit a Comment

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
brightcove.createExperiences();